Navigation Links
PainCare Holdings and MedeFile International Form Partnership to Market Personal Electronic Medical Records Direct to Consumers
Date:10/17/2007

ORLANDO, Fla. and CEDAR KNOLLS, N.J., Oct. 17 /PRNewswire-FirstCall/ -- PainCare Holdings, Inc. (Amex: PRZ), one of the nation's leading providers of pain-focused medical and surgical solutions and services, and MedeFile International, Inc. (OTC Bulletin Board: MDFI), a company specializing in portable electronic medical records management solutions, today jointly announced the formation of a partnership created to market the MedeFile system, a proprietary personal electronic medical records management solution, direct to consumers nationwide.

Pursuant to the terms and conditions of the agreement, PainCare will be granted exclusive rights to market the MedeFile system direct to consumers in exchange for a 50% share of revenues generated strictly from PainCare's marketing activities. With plans to produce a national television informercial scheduled to begin airing in January 2008, PainCare has agreed to also support this marketing initiative with direct response advertising on the Internet and via direct mail.

According to Randy Lubinsky, CEO of PainCare, "Through its business relationship with our subsidiary Integrated Pain Solutions (IPS), MedeFile's management team has spent considerable time educating our corporate leadership on the tremendous benefits and competitive differentiation of the MedeFile system. In light of PainCare's underpinning mission to improve the standard of patient care in the U.S., we quickly determined that the MedeFile system represented a true patient-empowering solution that could yield material enhancements in the universal management of health records - particularly for those with chronic medical issues requiring care by multiple physicians. Consequently, PainCare believes tha
'/>"/>

SOURCE PainCare Holdings, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine news :

1. International community warns India on HIV situation
2. Key step forward on International Health Rules
3. ICMR along with other International Research organisation with drug development for Neglected Diseases
4. International Osteoporosis Research Centre To Be Started In India.
5. Indian hospitals require International Accreditation
6. International Conference On Malaria - Laveran To Genomics
7. Delhi To Host International Women’s Congress From Nov 2
8. International conference on Ayurveda to be held on Kerala
9. International Teleradiology: The Future Of Radiologic Diagnosis
10. International Rating System To Be Introduced For Hospitals In India
11. John Mendelsohn M.D, chosen for an International Award
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/8/2009)...ONTO, Jan. 8 /PRNewswire-FirstCall/ - Med-Emerg In... Canada,s leading providers of health services, is...ted in favour of the previously announced plan of ...oup Inc. ("AIM") at a special meeting of MedEmerg,... 90% of the votes cast at the meeting were in favo...
(Date:1/8/2009)...XANDRIA, Va., Jan. 8 To...nization along with several national leadership or... the principles of hospice care and protection of ...anding together in sharing this unified message ab...of Hospice and Palliative Medicine, Hospice and Pa...
(Date:1/8/2009)...ifornia Assembly Member Tom Torlakson Introduces A...-USNewswire/ -- Today, Lung Cancer Alliance-Cali... Tom Torlakson (D-11th District) for his continued...unding for lung cancer research. For the third co...ancer research is being considered in the Californ...
(Date:1/8/2009)...says it lowered bad cholesterol more effectively t...y News) -- After nearly a year of review, U.S. hea...e continued use of the controversial cholesterol-l...Administration said there was no significant diffe... taking Vytorin and patients taking the drug Zocor...
Breaking Medicine News(10 mins):Health News:Shareholders of Med-Emerg International Inc. approve plan of arrangement with AIM Health Group Inc. 2Health News:National End-of-Life Organizations Release Consensus Statement on Hospice, the Medicare Hospice Benefit, and Key Issues for the Future 2Health News:National End-of-Life Organizations Release Consensus Statement on Hospice, the Medicare Hospice Benefit, and Key Issues for the Future 3Health News:National End-of-Life Organizations Release Consensus Statement on Hospice, the Medicare Hospice Benefit, and Key Issues for the Future 4Health News:National End-of-Life Organizations Release Consensus Statement on Hospice, the Medicare Hospice Benefit, and Key Issues for the Future 5Health News:National End-of-Life Organizations Release Consensus Statement on Hospice, the Medicare Hospice Benefit, and Key Issues for the Future 6Health News:National End-of-Life Organizations Release Consensus Statement on Hospice, the Medicare Hospice Benefit, and Key Issues for the Future 7Health News:Lung Cancer Alliance Applauds New Legislation Funding Lung Cancer Research 2Health News:FDA Backs Cholesterol Drug Vytorin 2
... walk and stick to healthy food. That is a far mor... a group of US scientists has said.// In fact pr...tified when lifestyle changes are just as effectiv...osiglitazone pills do work, but so does weight los...
...ch has shown a way for people suffering diabetic r...arding as well as alleviating the effects of diabe... consequence of diabetes. In the initial stages, ...le symptoms but is capable of progressing graduall...
... outcomes for blacks with cardiovascular disease a...ferences in access and treatment are minimized, ac...rt Journal, Reuters reports. For the study, Nanc...emorial Veterans Hospital and colleagues studied t...
...w of the massacre that took place last week at the...iversity officials are asking the congressmen to f...isaster. Some kind of program, to identify and tre... and the others. A law that would permit the unive...
Other Medicine News:Health News:Lifestyle changes not prescription drugs to fight diabetes, say scientists 2Health News:Measures Needed to Avert Another Bloodbath 2
(Date:1/6/2009)... In recent controlled studies cond...is , scientists found that the patented ingredient...only proven ingredient to increase levels of nitri... nitrate/nitrate (NOx) in human subjects. , , N...ncrease in blood flow to the skeletal muscles. Th...
(Date:1/6/2009).... 6 Cequent Pharmaceuticals, a pio...er RNAi-based treatments to prevent and treat huma... completed a successful toxicology study of its ca...erapeutic targeting the primary oncogene (beta-cat...is). FAP is an inherited gastrointestinal disease ...
(Date:1/5/2009)...Newswire/ -- Cylene Pharmaceuticals announced toda...f its oral CK2 protein kinase inhibitor, CX-4945, ...s disease, or multiple myeloma. The primary endpoi...ation of safety, tolerance and PK properties of CX... II trials. In addition, multiple mechanism-relate...
(Date:1/3/2009)..., , ROSEMONT, Ill., Jan. 2 /PRNewswire-USNewswi...ng technology providing an increasing number of cl...k pain according to an article in the January 2009...rthopaedic Surgeons ( http://www.jaaos.org/ ). It...ditional technical developments will allow MRI to ...
Breaking Medicine Technology:US Testing Proves Glyc'n Go(TM) Increases NO in the Blood Stream 2Cequent to Present First Proof of Activity of an Oral RNAi Drug in Non-Human Primates at February Keystone Conference 2Cequent to Present First Proof of Activity of an Oral RNAi Drug in Non-Human Primates at February Keystone Conference 3Cylene Pharmaceuticals Initiates Phase I Trial With CX-4945 -Breakthrough First-in Class Inhibitor of CK2 2Cylene Pharmaceuticals Initiates Phase I Trial With CX-4945 -Breakthrough First-in Class Inhibitor of CK2 3MRI Emerges As Vital Resource in Treatment of Back Pain 2MRI Emerges As Vital Resource in Treatment of Back Pain 3Atria Bills Get Support From Assisted Living Residents Family Members Senior Groups 13314 1Atria Bills Get Support From Assisted Living Residents Family Members Senior Groups 13314 2Unfavorable ocean conditions likely cause of low 2007 salmon returns along West Coast 2381 1Unfavorable ocean conditions likely cause of low 2007 salmon returns along West Coast 2381 2AMA Asks Patients 3A Do You Know Whats in Your Medicine Cabinet 3F 13312 1AMA Asks Patients 3A Do You Know Whats in Your Medicine Cabinet 3F 13312 2mtvU 26 The Jed Foundation Go Beyond March Madness Spring Break 26 5th Anniversary of Iraq War Dedicating March Programming to College Students Me 13310 1mtvU 26 The Jed Foundation Go Beyond March Madness Spring Break 26 5th Anniversary of Iraq War Dedicating March Programming to College Students Me 13310 2mtvU 26 The Jed Foundation Go Beyond March Madness Spring Break 26 5th Anniversary of Iraq War Dedicating March Programming to College Students Me 13310 3mtvU 26 The Jed Foundation Go Beyond March Madness Spring Break 26 5th Anniversary of Iraq War Dedicating March Programming to College Students Me 13310 4mtvU 26 The Jed Foundation Go Beyond March Madness Spring Break 26 5th Anniversary of Iraq War Dedicating March Programming to College Students Me 13310 5mtvU 26 The Jed Foundation Go Beyond March Madness Spring Break 26 5th Anniversary of Iraq War Dedicating March Programming to College Students Me 13310 6
...NESS WIRE)--Jun 25, 2007 - Elixir,Pharmaceuticals,...,data highlighting the ability of Glufast(R) (miti...on therapy with metformin, to,manage glucose surge...in the Abstract Book for the American Diabetes,Ass...o, Illinois.,Glufast is an insulin secretagogue th...
...WIRE)--Jun 25, 2007 - CytRx Corporation,(NASDAQ:CY...velopment and commercialization of human therapeut...s from its previously,announced double-blind, plac...l in healthy volunteers with its drug candidate,ar... trial support,the use of arimoclomol in future cl...
Other Medicine Technology:Elixir Pharmaceuticals Announces Clinical Data at American Diabetes,Association Conference Highlighting Ability of Glufast to Maintain,Glycemic Control in Patients with Type 2 Diabetes 2Elixir Pharmaceuticals Announces Clinical Data at American Diabetes,Association Conference Highlighting Ability of Glufast to Maintain,Glycemic Control in Patients with Type 2 Diabetes 3Elixir Pharmaceuticals Announces Clinical Data at American Diabetes,Association Conference Highlighting Ability of Glufast to Maintain,Glycemic Control in Patients with Type 2 Diabetes 4Elixir Pharmaceuticals Announces Clinical Data at American Diabetes,Association Conference Highlighting Ability of Glufast to Maintain,Glycemic Control in Patients with Type 2 Diabetes 5CytRx Announces Clinical Results from Its Rising Multiple Dose,Trial with Arimoclomol for ALS 2CytRx Announces Clinical Results from Its Rising Multiple Dose,Trial with Arimoclomol for ALS 3CytRx Announces Clinical Results from Its Rising Multiple Dose,Trial with Arimoclomol for ALS 4CytRx Announces Clinical Results from Its Rising Multiple Dose,Trial with Arimoclomol for ALS 5
Angled shafts with 4 mm tying patform. Serrated handle with dull finish. Most popular size or model. Overall length 3.2 inches.
Angled 45 degree shafts 8 mm from tip to bend with 4 mm tying platform. Smooth handle with dull finish. Overall length 3.2 inches.
Curved shafts and tips with 6 mm tying platform. Wide serrated handle with dull finish. Overall length 4.3 inches.
Ultra-fine tying platform with round knurled handle for fingertip rotational control. Straight shafts. Overall length 3.9 inches.
Medicine Products: